Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
DuMont, Ashley L
Yoong, Pauline
Liu, Xiang
Day, Christopher J
Chumbler, Nicole M
James, David BA
Alonzo, Francis
Bode, Nadine J
Lacy, D Borden
Jennings, Michael P
Torres, Victor J
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2014
Size
File type(s)
Location
License
Abstract

The bicomponent leukotoxins produced by Staphylococcus aureus kill host immune cells through osmotic lysis by forming ??-barrel pores in the host plasma membrane. The current model for bicomponent pore formation proposes that octameric pores, comprised of two separate secreted polypeptides (S and F subunits), are assembled from water-soluble monomers in the extracellular milieu and multimerize on target cell membranes. However, it has yet to be determined if all staphylococcal bicom- ponent leukotoxin family members exhibit these properties. In this study, we report that leukocidin A/B (LukAB), the most di- vergent member of the leukotoxin family, exists as a heterodimer in solution rather than two separate monomeric subunits. No- tably, this property was found to be associated with enhanced toxin activity. LukAB also differs from the other bicomponent leukotoxins in that the S subunit (LukA) contains 33- and 10-amino-acid extensions at the N and C termini, respectively. Trun- cation mutagenesis revealed that deletion of the N terminus resulted in a modest increase in LukAB cytotoxicity, whereas the deletion of the C terminus rendered the toxin inactive. Within the C terminus of LukA, we identified a glutamic acid at position 323 that is critical for LukAB cytotoxicity. Furthermore, we discovered that this residue is conserved and required for the inter- action between LukAB and its cellular target CD11b. Altogether, these findings provide an in-depth analysis of how LukAB tar- gets neutrophils and identify novel targets suitable for the rational design of anti-LukAB inhibitors.

Journal Title

Infection and Immunity

Conference Title
Book Title
Edition
Volume

82

Issue

3

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2014 American Society for Microbiology. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.

Item Access Status
Note
Access the data
Related item(s)
Subject

Biological sciences

Agricultural, veterinary and food sciences

Biomedical and clinical sciences

Medical bacteriology

Microbiology

Immunology

Medical microbiology

Persistent link to this record
Citation
Collections